Unicycive Therapeutics, Inc. (UNCY)
3.59
-0.11
(-2.97%)
USD |
NASDAQ |
Oct 15, 16:00
3.65
+0.06
(+1.67%)
After-Hours: 20:00
Unicycive Therapeutics EPS Diluted (Quarterly) : -0.064 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.064 |
| March 31, 2026 | -0.5363 |
| December 31, 2025 | -0.6633 |
| September 30, 2025 | -0.3327 |
| June 30, 2025 | -0.5241 |
| March 31, 2025 | -0.0502 |
| December 31, 2024 | -1.891 |
| September 30, 2024 | -0.046 |
| June 30, 2024 | 0.0803 |
| March 31, 2024 | -0.6064 |
| December 31, 2023 | -0.2244 |
| September 30, 2023 | -0.135 |
| June 30, 2023 | -0.2915 |
| March 31, 2023 | -0.9568 |
| Date | Value |
|---|---|
| December 31, 2022 | -0.3498 |
| September 30, 2022 | -0.3689 |
| June 30, 2022 | -0.2419 |
| March 31, 2022 | -0.2357 |
| December 31, 2021 | -0.1835 |
| September 30, 2021 | -0.3474 |
| June 30, 2021 | -0.0758 |
| March 31, 2021 | -0.0632 |
| December 31, 2020 | -0.0577 |
| September 30, 2020 | -0.046 |
| June 30, 2020 | -0.0222 |
| March 31, 2020 | -0.0226 |
| December 31, 2019 | -0.046 |
| September 30, 2019 | -0.037 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.722M |
| Total Expenses (Quarterly) | 1.722M |
| Enterprise Value | 39.31M |
| Earnings Yield | -44.47% |
| Normalized Earnings Yield | -40.65 |